These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9543118

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [New conditions for the use of growth hormone and outcomes for different indications].
    Rochiccioli P, Tauber MT.
    Ann Endocrinol (Paris); 1998 Nov; 59(4):296-9. PubMed ID: 9864549
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preterm growth restraint: a paradigm that unifies intrauterine growth retardation and preterm extrauterine growth retardation and has implications for the small-for-gestational-age indication in growth hormone therapy.
    Wit JM, Finken MJ, Rijken M, de Zegher F.
    Pediatrics; 2006 Apr; 117(4):e793-5. PubMed ID: 16567394
    [No Abstract] [Full Text] [Related]

  • 7. [Intrauterine treatment of growth retardation].
    Díez JJ.
    Med Clin (Barc); 1999 May 08; 112(16):616-8. PubMed ID: 10374177
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone: diagnostic and therapeutic dilemmas.
    Morris AH, Reiter EO.
    Semin Adolesc Med; 1987 Dec 08; 3(4):283-91. PubMed ID: 3324248
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth hormone treatment of short stature due to intrauterine growth retardation.
    Stanhope R.
    Clin Endocrinol (Oxf); 2000 Dec 08; 53(6):665-6. PubMed ID: 11155086
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Managing children with Russell-Silver syndrome: more than just growth hormone treatment?
    Christoforidis A, Maniadaki I, Stanhope R.
    J Pediatr Endocrinol Metab; 2005 Jul 08; 18(7):651-2. PubMed ID: 16128241
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M, Hochberg Z.
    J Clin Endocrinol Metab; 2002 Aug 08; 87(8):3573-7. PubMed ID: 12161476
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
    Hujeirat Y, Hess O, Shalev S, Tenenbaum-Rakover Y.
    Horm Res; 2006 Aug 08; 65(4):210-6. PubMed ID: 16582564
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth hormone for normal short children.
    Med Lett Drugs Ther; 2003 Nov 10; 45(1169):89-90. PubMed ID: 14603098
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.